biOasis Technologies Ord Shs V.BTI.H

Forcing Bioasis to Answer

[Boomskid]

As you know, I have not stated on here how I think people should vote. In fact, I have stated that unless the consequences of a "No" vote are known, it's dangerous to vote "No" because of the Lind foreclosure possibilities and the subsequent loss of Bioasis intellectual properties.

I could read the hundreds of pages in the dozens of documents that Bioasis has posted to SEDAR. I may even be able to correctly figure out what would happen with a "No" vote. But I can't and won't give legal advice or even express my opinion about this in public.

It's a question for Bioasis to answer. Bioasis management and Graeme at Colwell have a responsibility to answer, in full, the question about the consequences of voting "no."

My understanding is that when asked the question, GD's response is that "There is no Plan B."

That response is cavalier and meaningless. He should be ashamed of it. Using the analogy of chess, the king can be in check or can be checkmated. With a checkmate there is no Plan B. You've been beaten. If you're in check then you have moves that may or may not save you.

Bioasis shareholders need to know whether they've been checkmated, to be told whether a "No" vote will cause the certain loss of xB3 and all of Bioasis's IP to Lind. 

To say there is "no Plan B" can mean that there may be no Plan B but one could be formed and executed. Or "no Plan B" could mean that there is no possible Plan B that would save Bioasis from this deal.

Graeme needs to be given instructions by Bioasis on how to ACCURATELY answer all questions about the deal, including questions about Lind's rights, the payouts for cancelling the deal and other costs associated with exiting the deal.

Calls to and from Graeme and Zoom calls with Dr. Deborah Rathjen need to focus on the unequivocal answers to these questions and not on the obfuscation of "There is no Plan B."

Hold their feet to the fire in your calls to them!!

And remember, if you've already voted, you can change your vote if new and more complete information is available to you.

And it's not enough for Bioasis to say that everything you need to know is in the dozens of legal documents with hundreds of pages to be found on SEDAR and in other filings by Midatech and others. It might be legally enough, but hiding behind that law is not an expression of faithfulness to shareholders. 

jd

[prophetoffactz]

"My understanding is that when asked the question, GD's response is that "There is no Plan B."" I don't know what's been said but based on the company's public information it has looked to me like the Midatech deal was 'Plan B'. 'Plan A' was the Cresence deal to transform BTI into a clinical stage company and get on NASDAQ. This was supported by

[Boomskid]

Cresence was Plan B?!!!??? The Cresence people got 6 million shares or so. Those shares are now worth about $250,000. They aren't Plan B and they never were Plan B. In my opinion, they were likely part of a storyboard developed to promote this sellout. I don't think that LT and The Placee bought Midatech and Bioasis for the Cresence stuff. It's about xB3. Even Stephen Stamp of

[prophetoffactz]

"Cresence was Plan B?!!!??? The Cresence people got 6 million shares or so. Those shares are now worth about $250,000. They aren't Plan B and they never were Plan B. In my opinion, they were likely part of a storyboard developed to promote this sellout." I said Cresence appears to have been 'Plan A' with the J&J and Neuramedy deals. Marketing BTI as a Phase II

[Boomskid]

Oh, Cresence is plan A. I misunderstood. Along with a J&J deal that we know nothing about and a Neuramedy that was another "four bats and a bag of balls" deal, Cresence is/was "Plan A." You do understand, poof, I'm sure, that if xB3 can make losers like the Cresence and Neuramedy stuff into winners that xB3 can also be used for: Brain tumours MS PD

[prophetoffactz]

"Do you think that the Ellipses leak signalled that deals that would have been transformational for Bioasis and would have provided validation of the xB3 platform by leveraging the synergy between Bioasis and each of its partners would have helped to calalyze a financial and corporate renaissance for Bioasis?" The only time I've seen Ellipses is what you've posted. I have no

[Boomskid]

So, poof, have you considered the possibility that there are two or more xB3 deals that could be done with Ellipses? xB3-001 is one, obviously. That one deals with HER2+ but not other HER2 (triple neg, for instance) types of breast cancer and metastases. The Ellipses/SunRock drug, EP0017, is also a likely candidate for transport across the BBB. It's a fusion protein targeting HER3 (and DR

[prophetoffactz]

"Your may be making the case for even more Bioasis business with Ellipses, not less business." What could a strategic alliance in cancer look like between Biodexa and Ellipses or another company? Just like BTI has an alliance for Lysosomal Storage Disorders with a single company(ie., Chiesi) it could have a strategic alliance with a single company in cancer. Dealing with a single

[Boomskid]

A strategic alliance between Biodexa and Ellipses would mean that 94% of the benefits of such deals would go to people and companies other than to Bioasis and its shareholders. Is that lost on you, poof? Bioasis had a presentation detailing a deal with Ellipses. What was that? Where did that go? It stinks to its very core, poof. jd

[emmitfitzhume]

5 weeks ago, BTI was about a 12.4 million Canadian market cap company, now it is a 3.4 million Canadian market cap company, that’s a 27% drop from its former value on the announcement of this deal.  According to the terms of this deal, we will then own six percent of this new company, of which BTI assets are valued at just 3.4 million dollars as of close of market today.  As this simple

[prophetoffactz]

"A strategic alliance between Biodexa and Ellipses would mean that 94% of the benefits of such deals would go to people and companies other than to Bioasis and its shareholders. Is that lost on you, poof?" We've went over that.  Midatech holders(including outstanding Midatech warrants) get ~10% of the fully diluted company. BTI shareholders(including outstanding BTI warrants

[Boomskid]

poof says, "To me this looks like a takeover of Midatech by Bioasis." I can't help but imagine that even poof was giggling after he wrote that line. He is capable of sufficient hubris.to think he could get away with it. I guess it's a time when a good laugh is a good thing. Ha ha. Ha jd

[prophetoffactz]

I don't know if you are a socilist or not, jd; but don't you think like one? You talk about BTI getting 6% of the deal and don't want to count BTI's outstandng warrants, the bridge loan to BTI, the Lind obligations. You seem to want Ladenberg Thalmann to work for free and not count them as an obligation. The markets have been very difficut, a historic bear market, and you seem to

[Boomskid]

About the warrants that you say I don't want to talk about, poof, maybe I missed something but why would anybody exercise a warrant at a price any higher than 4.5¢? Or 3.3¢ if you consider the MTP share price? Those warrants range in exercise price from 20¢ to 67¢. Would you explain to the warrant holders why they should exercise them when they're 20,000 leagues under

[emmitfitzhume]

And before anyone highlights to me the benefits we are receiving as a Biodexa shareholder, yeah, it is not lost on me that we will be getting Midatech assets.  And I’m sure they have a swell pipeline with wonderful assets, but they are already a Nasdaq listed company and as broke or more broke than we are.  This whole concept of combing two wrongs to make a right seems rather clown

[prophetoffactz]

"And before anyone highlights to me the benefits we are receiving as a Biodexa shareholder, yeah, it is not lost on me that we will be getting Midatech assets." I think you really do have to look at the upside of the deal to make sense of the deal. There are two companies with shareholders unfamiliar with each companies assets and that can lead to serious problems. The dilution is easy

[emmitfitzhume]

1.62 % of any future XB3 success compared to our share 5 weeks ago. that is all that is left for Bioasis shareholders in the new structure. Show me where am I wrong in this analysis POF?

[prophetoffactz]

I've done the best that I can. With all obligations settled Midatech and BTI get 33% of the upside of Biodexa as below. The company will hopefully be viable with a cash runaway to key catalysts. Midatech's assets from glioblastoma to Q-Sphera have been in human trials and are therefore de-risked to a degree. xB3 may be two years from a clinical trial. Preclinical assets are generally much

[Boomskid]

Magic math, poof. How can shareholders with 6% of the company get 33% of the upside? Again, what is it about 3.3¢ per share that is excaping you? What is it about LT and The Placee with over 75% of the company that is escaping you? You can do yer number doodling all you want but investors on AIM, NASDAQ and TSXV are saying you're full of it. That's not me. That's the market

[emmitfitzhume]

So you contend that 1.62% of future XB3 success compared to where we were 5 weeks ago is an acceptable term for current shareholders? I think that a more equitable deal could have been explored. Or, XB3 simply doesn’t work.  That is the only scenario in which such a deal makes sense. Seems rather clear to me.

[prophetoffactz]

BTI and Midatech holders received 33% of the upside of Biodexa, as outlined, and that appears reasonable under the very difficult circumstances. There has been significant improvement in stocks since the deal was put together. Midatech's CEO said he could have put together an alternative financial package. Perhaps the second warrant could be eliminated; but the financing needs to be priced to

[emmitfitzhume]

POF Just for perspective, a 780 million dollar private placement done at our prior valuation or 13 million would dilute us down to about 1.6%, that’s the percentage shareholders will have in any future success of xb3 in this new structure.  Can we not call that crippling dilution?  Could there have been no other options which would respect current shareholders, potentially at the cost

[Boomskid]

emmit, excellent post. Your earlier calculation was a good reflection of reality. It's a little different than saying that Bioasis is acquiring Midatech and shereholders will get 33% of the upside. If I could give you a few hundred of poof's thumbs, I would. jd

[narmac]

There is always a Plan B and a pPan C,,,dont kid yourself,,,,these deal makers know exactly what they want to do if the vote is a favourable "NO". Hahahahahahaaha,,, ,,They will come out guns ablazing to take our IP,,,, but they will be confronted with a shareholder take over. Perhaps we could negotiate Mark Day back in the saddle. Pick our own board. Downsize,, raise the $$ for Linds

[fuzzyjr]

" we could negotiate Mark Day back in the saddle" What??? you'd prob hav jd as a consultant too eh - I already know your answer - u guys must have some new bird flew , right out of the koo 's nest.  if I knew any part of this including the rest of your plan is the plan b being considered or comes into play & soon I'd sell everything immediately. Like

[beenthere]

" Mark Day" ? You talking about the guy with that "bright idea" to move to the US and pay all our expenses with those tiny Can dollars  AND not gaining a darn thing in the process? Thank you but no thank you! NO!